Mumbai: Renowned laparoscopic onco-gynaec surgeon and founder of Eva Women’s Hospital, Dr. Dipak Limbachiya, has achieved a significant academic milestone with the publication of two more of his research studies in reputed international medical journals. The papers focus on advanced surgical techniques for endometrial cancer and bowel endometriosis, two highly challenging areas in gynaecological oncology.
Endometriosis primarily manifests through pelvic pain, which is often linked to menstrual periods in most women. For those affected, menstrual pain can be far more severe than usual. The condition also brings a host of other symptoms, including pain during sexual intercourse, bowel movements, or urination, heavy menstrual periods or bleeding between periods, and additional issues like abdominal bloating, nausea, fatigue, depression, anxiety and infertility.
One of the studies, published in the Journal of the Society of Laparoscopic & Robotic Surgeons (SLS), addressed the management of bowel endometriosis, a condition affecting up to a third of women with severe endometriosis and often causing debilitating symptoms. Dr. Limbachiya and the study’s co-authors evaluated a single-stapler laparoscopic resection and anastomosis technique in 17 patients treated between January 2023 and June 2024. Most women presented with progressive dysmenorrhoea, painful intercourse, and painful bowel movements.
The novel surgical approach enabled tension-free resections with clear margins, with no need for diversion stomas. Post-operative recovery was described as smooth across all cases, with patients experiencing a clear relief in symptoms and no major complications. The study underscores the feasibility, safety, and efficacy of this minimally invasive approach, which offers excellent outcomes with significant symptom relief for affected women.
Another study, centred on endometrial carcinoma, analysed the role of intra-operative frozen section (IFS) in improving the accuracy of surgical decisions. Conducted on 100 patients who underwent laparoscopic staging surgery between March 2018 and September 2024, the research assessed tumour type, grade, depth of myometrial invasion and lymph node involvement.
Results showed that IFS achieved a 97% concordance with final histopathology in detecting malignancy, with particularly strong reliability in assessing myometrial invasion (93.7% accuracy), lymph node involvement (98.3% accuracy), and tumour grading (78.2%). The study, published in Science Direct, concluded that IFS remains a powerful intra-operative tool that can guide surgeons in tailoring the extent of surgery, thereby reducing unnecessary morbidity.
Speaking on the two studies, Dr. Limbachiya, who has also published papers in other prestigious medical journals, said, “Both studies reflect years of dedicated efforts and research aimed at improving outcomes for women suffering from complex gynaecological conditions. The publication of these findings in international journals is both humbling and motivating. At Eva Women’s Hospital, we remain committed to advancing minimally invasive surgical techniques that prioritise patient safety and offer faster recovery and long-term relief.”
Beyond his surgical practice, Dr. Limbachiya is also deeply committed to education and mentorship. He has, since 2012, trained over 4000 doctors from around the world, equipping them with the skills to deliver superior care, ensuring that advancements in laparoscopic surgery benefit patients globally. His innovative surgical techniques have been widely adopted by the medical community.
Eva Women’s Hospital is a leading institution dedicated to women’s health. The hospital has been at the forefront of providing world-class care for over two decades, particularly in the treatment of endometriosis. Its recently expanded centre is equipped with advanced technology for complex laparoscopic and oncological surgeries.
The hospital takes pride in being a single super-speciality centre, where doctors and staff work together with the mission of providing the best care for every patient. Its operation theatres are equipped with the most advanced integrated OR system by Germany’s Karl Storz, the first-of-its-kind in Gujarat. The hospital uses a state-of-the-art plasma sterilisation system to ensure 100% infection control.
“Our promise at EVA Women’s Hospital is the best patient care, backed by technology and world-class infrastructure,” Dr. Limbachiya added.
